These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 18380278

  • 1. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L, Fisher B, Bauman G, Macdonald D.
    Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
    [Abstract] [Full Text] [Related]

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 3. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
    Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):993-1001. PubMed ID: 17967517
    [Abstract] [Full Text] [Related]

  • 4. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan 15; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 5. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 6. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC, Herndon JE, Rosenman J, Carey RW, Chung CT, Bernard S, Leone L, Seagren S, Green M.
    J Clin Oncol; 1998 Nov 01; 16(11):3528-36. PubMed ID: 9817271
    [Abstract] [Full Text] [Related]

  • 7. Reirradiation and lomustine in patients with relapsed high-grade gliomas.
    Arcicasa M, Roncadin M, Bidoli E, Dedkov A, Gigante M, Trovò MG.
    Int J Radiat Oncol Biol Phys; 1999 Mar 01; 43(4):789-93. PubMed ID: 10098434
    [Abstract] [Full Text] [Related]

  • 8. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer.
    Uitterhoeve AL, Belderbos JS, Koolen MG, van der Vaart PJ, Rodrigus PT, Benraadt J, Koning CC, González González D, Bartelink H.
    Eur J Cancer; 2000 Mar 01; 36(5):592-600. PubMed ID: 10738123
    [Abstract] [Full Text] [Related]

  • 9. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
    Klobukowski L, Falkov A, Chelimo C, Fogh SE.
    Clin Oncol (R Coll Radiol); 2018 Sep 01; 30(9):563-570. PubMed ID: 29891395
    [Abstract] [Full Text] [Related]

  • 10. [The possibilities of fractionated external beam repeat irradiation of relapsed primary brain tumours: the first Hungarian experience].
    Mangel L, Sipos L, Fedorcsák I, Viola A, Julow J, Bajcsay A, Németh G, Fodor J.
    Orv Hetil; 2007 Sep 30; 148(39):1843-9. PubMed ID: 17890172
    [Abstract] [Full Text] [Related]

  • 11. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J, Neil E, Terziev R, Gutin P, Barani I, Kaley T, Lassman AB, Chan TA, Yamada J, DeAngelis L, Ballangrud A, Young R, Panageas KS, Beal K, Omuro A.
    Int J Radiat Oncol Biol Phys; 2017 Nov 15; 99(4):797-804. PubMed ID: 28870792
    [Abstract] [Full Text] [Related]

  • 12. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.
    Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):51-7. PubMed ID: 21035955
    [Abstract] [Full Text] [Related]

  • 13. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas.
    Hundsberger T, Brügge D, Putora PM, Weder P, Weber J, Plasswilm L.
    J Neurooncol; 2013 Mar 01; 112(1):133-9. PubMed ID: 23314822
    [Abstract] [Full Text] [Related]

  • 14. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 01; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 15. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ.
    Cancer; 1996 Apr 15; 77(8):1535-43. PubMed ID: 8608540
    [Abstract] [Full Text] [Related]

  • 16. Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors.
    Chamberlain MC, Barba D, Kormanik P, Berson AM, Saunders WM, Shea MC.
    Arch Neurol; 1995 Feb 15; 52(2):162-7. PubMed ID: 7848125
    [Abstract] [Full Text] [Related]

  • 17. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):57-63. PubMed ID: 9422558
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).
    Laing RW, Warrington AP, Graham J, Britton J, Hines F, Brada M.
    Radiother Oncol; 1993 Apr 01; 27(1):22-9. PubMed ID: 8327729
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma.
    Kocher M, Kunze S, Eich HT, Semrau R, Müller RP.
    Strahlenther Onkol; 2005 Mar 01; 181(3):157-63. PubMed ID: 15756519
    [Abstract] [Full Text] [Related]

  • 20. [Role of radiotherapy in recurrent gliomas].
    Dhermain F, de Crevoisier R, Parker F, Cioloca C, Kaliski A, Beaudre A, Lefkopoulos D, Armand JP, Haie-Meder C.
    Bull Cancer; 2004 Nov 01; 91(11):883-9. PubMed ID: 15582893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.